Ignite Creation Date:
2024-05-06 @ 1:56 AM
Last Modification Date:
2024-10-26 @ 11:12 AM
Study NCT ID:
NCT01935128
Status:
COMPLETED
Last Update Posted:
2022-05-26
First Post:
2013-08-21
Brief Title:
Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to EverolimusReduced Tacrolimus in Renal Transplant Recipients Following Campath Induction
Sponsor:
University of Toledo Health Science Campus
Organization:
University of Toledo
Organization Data
Organization:
University of Toledo
Class:
OTHER
Study ID:
Everolimus
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Toledo Health Science Campus
Lead Sponsor Class:
OTHER
Responsible Party:
Michael A Rees MD PhD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Toledo Health Science Campus
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis Pharmaceuticals | INDUSTRY |